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Women’s views and experiences of two
alternative consent pathways for
participation in a preterm intrapartum
trial: a qualitative study
Alexandra Sawyer1* , Celine Chhoa2, Susan Ayers2, Angela Pushpa-Rajah3 and Lelia Duley4
Abstract
Background: The Cord Pilot Trial compared alternative policies for timing of cord clamping at very preterm birth at
eight UK hospitals. In addition to standard written consent, an oral assent pathway was developed for use when
birth was imminent. The aim of this study was to explore women’s views and experiences of two alternative
consent pathways to participate in the Cord Pilot Trial.
Methods: We conducted a qualitative study using semi-structured interviews. A total of 179 participants in the
Cord Pilot Trial were sent a postal invitation to take part in interviews. Women who agreed were interviewed in
person or by telephone to explore their experiences of two consent pathways for a preterm intrapartum trial. Data
were analysed using inductive systematic thematic analysis.
Results: Twenty-three women who gave either written consent (n = 18) or oral assent followed by written consent
(n = 5) to participate in the trial were interviewed. Five themes were identified: (1) understanding of the implications of
randomisation, (2) importance of staff offering participation, (3) information about the trial and time to consider
participation, (4) trial secondary in women’s minds and (5) reasons for agreeing to take part in the trial. Experiences
were similar for the two consent pathways. Women recruited by the oral assent pathway reported being given less
information about the trial but felt it was sufficient to make a decision regarding participation. There were gaps in
women’s understanding of the trial and intervention, regardless of the consent pathway.
Conclusions: Overall, women were positive about their experiences of being invited to participate in the trial. The
oral assent pathway seems an acceptable option for women if the intervention is low-risk and time is limited.
Trial registration: ISRCTN Registry, ISRCTN21456601. Registered on 28 February 2013.
Keywords: Clinical trials, Ethics, Consent, Oral assent, Preterm birth
Background
High-quality randomised trials are the gold standard for
evaluating interventions to improve outcomes for babies
born very preterm (<32 weeks of gestation), who are at
increased risk for neonatal complications and neurode-
velopmental problems [1, 2]. The Cord Pilot Trial
investigators compared alternative policies for timing of
cord clamping at very preterm birth at eight UK
hospitals [3, 4]. Very preterm birth can be rapid and un-
expected and is often a difficult and stressful time for
women and their partners, so approaching women to
offer participation in a randomised trial may be difficult.
Yet, these women often give birth to babies at high risk
of poor outcome; hence, it was particularly important
that they were offered the opportunity to be included in
the trial.
In addition to the usual procedure for written consent,
we therefore developed a two-stage ‘oral assent’ pathway
for consent for use when birth was imminent [4]. This
oral assent pathway was developed in partnership with
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parent representatives from Bliss, the special care baby
charity, and the National Childbirth Trust, and it is in
line with guidance on valid consent for research while in
labour [5]. The aim of this study was to describe
women’s views and experiences of the two alternative
consent pathways for participation in the Cord Pilot
Trial. Clinicians’ views and experiences are reported
elsewhere [6].
Methods
Consent pathways in the Cord Pilot Trial
To help ensure that women were aware of the trial, in-
formation about the study was widely available in clinics
and on wards at each hospital. Standard consent was the
usual one-stage pathway for written consent. If birth was
imminent (as the woman was in established labour or
before emergency caesarean section) and thus there was
insufficient time for this one-stage pathway, and the
attending clinicians considered it appropriate, women
were offered oral assent [4]. For oral assent, the woman
was given a brief description of the trial and a short in-
formation leaflet (see Additional file 1: Appendix A).
This process is in line with clinical governance advice
for valid consent for research while in labour issued by
the Royal College of Obstetricians and Gynaecologists
[7]. After being given a brief summary of the study, with
the opportunity to ask any questions, the woman was
asked if she was willing to be recruited. If she said yes,
she was randomised. If she did not give oral assent, she
was not recruited. How long was required for oral assent
depended on factors such as how much the woman
already knew about the study and her knowledge and
wishes about care during the third stage. After the
woman gave birth, she was approached again so that the
study could be explained in more detail, she could be
given the long participant information sheet (see
Additional file 1: Appendix B), any questions she had
could be answered, and she could provide written con-
sent for continued participation in follow-up.
Training in both pathways for consent was provided to
site staff, including both research staff and clinicians. For
the two-stage oral assent pathway, clinicians received
training in offering oral assent because owing to time
constraints, this could be undertaken only by the clini-
cians. The research staff received training in the second
stage in this pathway of obtaining written consent.
Training videos for obtaining consent in a range of clin-
ical scenarios were provided to sites, and these included
offering oral assent.
Of 945 women who were approached, 472 (50%) gave
consent, and 193 (20%) declined participation. If women
chose not to participate, they were informed that care
would continue according to usual care at their hospital.
The remaining women were discharged to home without
having gone into labour, gave birth before reaching a de-
cision, were transferred to another hospital or were not
enrolled for other reasons. Oral assent was offered to 93
women, of whom 84 (90%) gave assent and 77 (83%)
were randomised. Eight women who gave oral assent
provided written informed consent before randomisation
and so are considered within the group who were of-
fered the usual one-stage consent pathway. In total, 261
women were randomised, of whom 69 women were
randomised following oral assent alone (26% of women
recruited to the trial). Figure 1 displays the participant
flow in the study by consent pathway.
Participants and procedure
This was a qualitative study using semi-structured inter-
views (see Additional file 2 for reporting guidelines for
qualitative studies). A total of 179 women randomised to
the Cord Pilot trial between April 2013 and October
2014 were eligible for this study. An invitation letter was
sent by post to eligible women, along with a postage-
paid envelope and reply slip for them to complete and
return if they were willing to be interviewed. If there
was no response after 2 weeks, a reminder letter was
sent. Reminders were not sent to women whose baby
had died. Women who responded were contacted, and
an interview date was scheduled for a time convenient
to them, to take place either at their home or by tele-
phone. Interviews lasted approximately 30 minutes and
were carried out by a female research assistant (CC)
trained in qualitative methods. The interviewer would
introduce herself and explain the purpose of the re-
search. No one was present apart from the interviewer.
The interview schedule (Additional file 1: Appendix C)
consisted of open-ended questions to explore the
women’s views and experiences of being offered partici-
pation in the Cord Pilot Trial. Probes were used to
explore responses in more depth. Interviews were re-
corded and transcribed with all identifying information
removed. Data collection ended when data saturation
had been achieved, which was defined as when no new
findings/themes were evident in the data. Information
from the interviews was reviewed and discussed regu-
larly between two authors (AS and CC), and when it was
evident that no new themes were emerging, data collec-
tion ended.
Data analysis
Inductive thematic analysis [8] was used to identify and
analyse themes. Thematic analysis is a flexible research
tool which can provide a rich and detailed account of
the data. Compared with other, similar approaches
(e.g., interpretative phenomenological analysis, grounded
theory), thematic analysis is not theoretically bounded.
Braun and Clarke’s [8] six phases of thematic analysis was
Sawyer et al. Trials  (2017) 18:422 Page 2 of 9
followed: (1) familiarisation of the data, which involves the
researchers immersing themselves in the data by reading
and re-reading the data and noting any analytic observa-
tions; (2) coding, which involves generating labels for im-
portant features of the data which are generally relevant to
the research question; (3) searching for themes, which in-
volves looking across collected codes to identify similarity
in the data; (4) reviewing themes, ensuring the themes
correspond with both the coded extracts and the full data-
set; (5) defining and naming themes, which involves the
researchers conducting and writing a detailed analysis of
each theme; and (6) write-up, which involves the re-
searchers bringing together the analysis and data extracts
to present a coherent reflection of the data. NVivo version
10 software (QSR International Pty Ltd., Doncaster,
Australia) was used to manage codes and themes. For this
report, direct quotes are coded (number = participant
number; type of consent) to ensure anonymity.
Results
Of the 179 women invited to participate, 27 (15%)
responded and agreed to be interviewed. Three women
could not be contacted to arrange an interview, and one
later withdrew consent; hence, data for 23 (13%) women
are reported here. Of these, 18 had been randomised fol-
lowing the usual written consent and 5 following oral
assent with subsequent written consent. Women inter-
viewed gave birth between 25+2 and 31+6 weeks of gesta-
tion at seven of the eight hospitals taking part in the
trial. One woman had a twin pregnancy. The women
were between 20 and 43 years old (mean 33 years, SD
6); most were married or cohabiting (Table 1); and
almost half were educated to degree level. Two-thirds of
the women had a caesarean birth. Most babies were
home at the time of the interview, but one baby died
shortly after birth, and another was still in the neonatal
intensive care unit. Time between birth and the
Fig. 1 Participant flow with consent pathway
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interview ranged from 1 to 14 months (mean 7.2
months). All but three women gave birth on the same
day that they were randomised.
Five major themes emerged as important factors in
women’s experiences of the different consent pathways:
(1) understanding of the implications of randomisation,
(2) importance of staff offering participation, (3) infor-
mation about the trial and time to consider participa-
tion, (4) trial secondary in women’s minds and (5)
reasons for agreeing to take part in the trial.
Understanding of the implications of randomisation
Not many women interviewed in this study showed a
good understanding of randomisation and the reasoning
for randomisation in trials. This was evident among
women who were invited by formal written consent and
had time to read the information sheet, consult with
their partners and ask questions, as well as among the
women who gave oral assent and had relatively less time
to consider participation. Some women expressed a
strong preference to be in the deferred cord clamping
arm of the trial because they perceived delayed cord
clamping to have more health benefits for their baby and
therefore expressed disappointment that they were ran-
domised to immediate clamping:
‘But I was hoping I would have been randomised to
delay and I wasn’t, so slightly disappointed at that. I felt
disappointed at the time because I was thinking there
are some benefits of it being delayed. I would have
preferred to, because obviously that’s the research to see
if there are benefits. So I was kind of thinking well there’s
obviously some evidence enough to do a research trial
with the public to see if there could be, so I was kind of
thinking I would have preferred to have been there to see
some of the benefits’. (2, written consent)
One woman who had been allocated to immediate
clamping (standard care) said, ‘I thought that my part
wouldn’t help, because they didn’t do much, they just cut
it straight away and he was breathing. So I thought, I’m
not really involved am I’? (16, written consent). This in-
dicates a lack of understanding of RCTs, such as, in this
case, the importance of a control group. One woman
thought that she had ‘failed’ the trial because although
she was allocated to the deferred clamping arm of the
trial, the cord had to be cut before 2 minutes because it
was too short:
‘And then when I actually did give birth it was
interesting because I felt like I’d really failed the trial.
Because she couldn’t reach the bed so they had to cut
the cord, they couldn’t keep her attached for the 2
minutes’. (14, oral assent)
Importance of staff offering participation
Staff members’ manner when they spoke to women
about the trial was important to the women. All of the
women interviewed were positive about the staff who
approached them and offered consent. Some women,
particularly those who gave oral assent when birth was
imminent, mentioned the calm and professional attitude
of the recruiting staff at a time of considerable anxiety.
One woman describes how the doctor’s calm approach
helped her focus on what was being said:
‘He was very calm throughout the whole process, and I
think his authority in the room allowed me to focus on
what he was saying and to take on board what he was
saying, rather than focusing on the anaesthetists and
scanners and junior doctors. It was very much he
Table 1 Demographic information of the women and details
about the birth and recruitment to the trial
Characteristics n (%) (n = 23)
Highest level of education
GCSEs/O levels 2 (9)
A levels/diploma/City & Guilds 7 (30)
Undergraduate degree 7 (30)
Postgraduate degree 4 (17)
Professional qualification 3 (13)
Marital status
Married 11 (48)
Living with partner 9 (39)
Single 1 (4)
Other 2 (9)
Reason for preterm birth
Antepartum haemorrhage 3 (13)
Pre-labour rupture 8 (35)
Spontaneous preterm labour 6 (26)
Pre-eclampsia 2 (9)
Placental abruption 1 (4)
Serious pre-existing health conditionsa 3 (13)
Caesarean section
Yes 14 (61)
Gestational age
< 28 weeks 8 (35)
28–32 weeks 15 (65)
Consent pathway
Standard written consent 18 (78)
Oral assent 5 (22)
GCSE General Certificate of Secondary Education
aPre-existing conditions included severe asthma, Crohn’s disease and anti-phosphate
lipid syndrome
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talked to me directly, very clearly, concisely, didn’t mince
his words, didn’t beat around the bush. Just very
professional and very clear on what he was wanting
and what was being said to me’. (1, oral assent)
Many women also recalled that the staff were good at
providing clear explanations about the trial, which was
important because explanations were often taking place
in a stressful context. Women also commented on the
personable nature of the staff. For example, they were
described as being warm, kind, friendly, and reassuring:
‘He explained it, gave me information about it, which
I think at the time would have been hard to take in
except he was just so clear and very much like, this is
what it is, don’t worry about, you don’t have to worry
about it if you don’t want’. (22, written consent)
‘They were very personable, and they came to see me
in person to collect my consent form. They didn’t put
any pressure on me to consent, but it just meant that
rather than me just being a number being entered into
a trial they actually cared about me and wanted me
to consider it carefully and have the opportunity to
talk things through. So I thought that was good that
you had that kind of personal interaction. Because like
you said before it can be quite a stressful time going
through pregnancy that’s going to have a preterm baby,
so it was good that they did that’. (5, written consent)
The staff ’s friendly attitude was also mentioned by one
woman (written consent) as one of the reasons she con-
tinued in the trial. Two women also mentioned that the
research team were another source of support on the
neonatal unit:
‘Oh fine, [name] and the other girl whose name I can’t
remember, they came to see us every day to talk about
the trial. If we had any concerns, they were always
there, always around. Very supportive not just about the
trial, about everything we were going through. So I felt
very confident and being part of the trial I suppose gave
me an extra level of support in the unit because I had
another friendly face to see and talk to’. (12, oral assent)
Finally, the way staff presented the study to women
was important in terms of making them feel comfortable
to be able to say no to participation. This ‘no pressure’
approach was mentioned by 12 women (4 oral assent, 8
written consent) as one of the reasons they were happy
to participate in the trial:
‘Because I could have said no, there was no pressure.
It was presented in a manner that even under the
exceedingly stressful situation that we were in, it was
presented in a manner that it was my decision, it was
a yes or no. And if I had said no, they wouldn’t have
pushed it on me’. (1, oral assent)
Some women mentioned that who approached them
was important. For example, one woman thought it was
better that staff who were involved in their own or their
baby’s care did not approach them about the study. This
was because she would feel less pressured to say yes: ‘If
it was the obstetrician asking, I might say yes because it
seems like there might be more benefits. But I think that
it’s quite good that it’s the research team; I felt less pres-
sured’ (2, written consent). In contrast, another woman
said that it was better ‘to get invited from the doctors
that are going be involved. I think that’s probably the best
way to do it’ (23, written consent).
Information about the trial and time to consider
participation
All but one woman (oral assent) said they received suffi-
cient information about the trial to make the decision to
participate. However, when asked to elaborate on details
of the information, only ten women reported receiving
detailed information and being given sufficient time to
consider participation before making a decision.
‘Well, the research nurse talked to me, and then before
the birth when I was in labour, the paediatrician
talked to me in detail, and it was already really well
explained by the nurse and in the documents what
would happen.… You know, that’s the nice thing about
me not going into labour straight away. They gave me
the sheet and gave me as much time as I wanted to
think about it, to read about it, and to, definitely. I
think she came in the morning and she came back in
the afternoon, something like that, so several hours to
decide. I had decided in less than an hour I wanted to
sign to do that’. (3, written consent)
Of these women, one gave oral assent and nine gave
written consent. In this instance, the woman who gave
oral assent was approached and given information 1
week before going into labour but did not sign the con-
sent forms until after birth, because she wanted to con-
sult with her partner who was away. In contrast, five
women described receiving only a brief summary of the
trial, and of these, three women gave oral assent and
two women received written consent.
‘To be honest, that’s it. The conversation we had was
all such a blur before we went into surgery. It was
very much, “Would you like to be part of this trial?”’.
(4, oral assent)
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‘Not a great deal, to be honest. I haven’t really been
told an awful lot; I don’t really know how long they
did it for’. (6, written consent)
However, women understood that this was more be-
cause of the nature of the situation rather than anyone’s
fault. One woman who felt she did not have sufficient
time describes that ‘it was just the circumstance, not the
nature of the doctors presenting it’ (1, oral assent).
There were gaps in some women’s accounts regarding
the potential benefits and risks of participation, uncer-
tainty regarding which arm of the trial to which they
were randomised, and what they would be asked to do
for follow-up in the trial. Four women mentioned that
they did not know how long would they would be
followed and what they would have to do as part of this
follow-up:
‘I was clear about what would happen at delivery, but
I wasn’t clear … there was a lot going, maybe I was
told, but I can’t remember about sort of long term…. I
filled a questionnaire in when I come home. But I
don’t know what the long-term follow-up is as part of
it. I probably was told, but I can’t remember any of
that’. (2, written consent)
Three women mentioned that they were not told
which arm of the trial their baby was in and therefore
did not know whether their baby received deferred or
immediate cord clamping. Two of three of these women
gave birth via caesarean section, one under general an-
aesthesia. All three stated that they had not asked at the
time, but said that they would have liked to have been
told. Another woman (oral assent), who was randomised
to the deferred arm, described that her baby got cold
and she wished that she had been told of this particular
risk. One woman (written consent) misunderstood the
purpose of the trial. She thought the trial was to do with
care of the umbilical cord after birth.
Trial secondary in women’s minds
Women were approached about the study and invited to
participate at a time when they knew their baby was
going to be born too early; for some, the birth was
imminent. Unsurprisingly, therefore, the trial was a
minor event in comparison to the birth of their baby.
Twelve women discussed that they had lots of other
things going on at the time and that once they agreed to
participate in the trial, they did not give it much further
thought (three oral assent, nine written consent).
‘I think it was just that day, that’s how it was, really. I
had other things going on; I didn’t know when I was
going to be having a caesarean, so I kind of had other
things on my mind probably than thinking about the
trial. The trial was almost less of an importance for
me’. (2, written consent)
‘I think there’s so much going on at that precise moment
that it’s very hard to then categorise things and think,
“Oh, actually, yes, I’ve signed up for that, that would be
interesting”. I wasn’t even on that planet, you know. We
were too busy thinking, “Oh my god, I’m going to have
two babies in a minute, what are we going to do”? That
sort of thing. I think once I’ve signed, I kind of boxed it,
dismissed it and I was onto the next thing if that makes
sense. Not in a ruthless way of not caring, but just we’d
made our decision and that was it. We agreed to it, and
off we went, I think’. (4, oral assent)
Reasons for agreeing to take part in the trial
Women discussed a range of reasons for agreeing to par-
ticipate in the trial, the most common being that partici-
pation contributed to research:
‘Basically, I think it’s like anything, isn’t it. Without
research you don’t find out about things, so I totally
support research. That was our feeling behind it, that,
you know, if you don’t research these things, you don’t
find out about it, do you? We’re completely open to
research, and we think it’s a good thing, so it was
important to take part’. (8, written consent)
Many women (n = 13, 57%) also agreed to participate
because they believed the trial posed no risk of harm to
their baby and might give their baby a natural or better
start, which was particularly important because they
were going to be born very preterm.
‘Well, I guess I just thought it sounded like a nice idea,
and it made sense in terms of giving the baby the best
start. I guess because we were looking at kind of
having a premature baby that it seemed like that
would be a good idea for her if that was possible’.
(11, written consent)
‘Very easy decision, to be honest, because I knew there
would be no danger to the baby to be left on the cord.
I would have never if there was a risk, but I felt that
there was no risk so there wasn’t any query of it really.
It was easy as that’. (4, oral assent)
Four women mentioned that one of the reasons they
agreed to take part was that it was a simple trial and the
intervention seemed ‘natural’:
‘It’s just, I do think, like, just common sense that do
something like this would make sure that the baby get
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that good blood supply with all the nutrient and all
the goodness in it for little bit longer. So that’s why I
said that because I think it feels very natural’.
(20, written consent)
Three women said they agreed to take part because of
the possibility of seeing their baby being cared for beside
them at the birth: ‘Because when we were talking about
what was going to happen, it was definitely kind of one
of the benefits, that the baby would be right beside you
for a little bit longer’ (11, written consent). Some women
also mentioned that they were happy to take part be-
cause it seemed like a simple thing to do.
Discussion
The aim of this study was to explore women’s views and
experiences of two consent pathways for participation in
a randomised trial of timing of cord clamping at very
preterm birth: usual written consent or oral assent when
birth was imminent. Women’s overall experiences of re-
cruitment were similar, regardless of the consent path-
way. Women valued clinicians’ positive manner when
approaching them about the trial and felt they had ap-
propriate information about the study. Although women
recruited by oral assent had less detailed information at
the time they gave assent, the women understood the
time constraints and felt they were given sufficient infor-
mation to make their decision about participation.
Indeed, women who were recruited when birth was
imminent and there was little time to make a decision
felt it was easier to consider participation when clini-
cians provided minimal and clear information about the
trial, especially because the trial was secondary in their
minds at that time.
The main reason women gave for agreeing to partici-
pate in the trial was contributing to research that could
help improve future care. Altruistic motivation is a com-
monly cited reason for participating in research [9, 10].
Other motivations were that the intervention posed little
risk, seemed natural and might give the baby the best
start. The view that deferring clamping of the umbilical
cord is a more natural process might make recruitment
by oral assent more likely to be acceptable. None of the
women who gave oral assent mentioned or questioned
that they had not been asked to sign a consent form,
something which clinicians felt was an issue [6]. Some
clinicians considered that because women did not have
to sign anything at the point of oral assent there is not a
clear record of the assent process. However, clinicians
were asked to document in their notes that women had
given oral assent. This was highlighted as being espe-
cially important if a participant was to have later ques-
tioned whether she did actually consent to participate.
Some of the clinicians we interviewed also raised a
concern that the standard written consent form may be
off-putting to women because the form is ‘very legalistic’.
However, none of the women raised this concern.
Some of the women discussed that it was important
who approached them about participating in the trial.
Opinion varied about whether it should be someone
who was not involved in their care or someone who was
looking after them and their baby. Some clinicians also
thought that the person who approached women was
important. Specifically, they thought the most appropri-
ate person was one of the neonatal staff as part of their
antenatal counselling to women and their families [6]. In
this study, staff members’ ability to provide simple yet
clear explanations about what the research entailed and
their ‘no pressure’ approach were especially important to
women who were approached when birth was imminent,
given the stressful and time-critical context. These find-
ings support literature that highlights the impact of clin-
ical communication on potential participants’ decision
making when deciding whether to enter a trial [11, 12].
This has implications for training in consent for intrapar-
tum and perinatal trials or in other trials where consent is
time-critical. Messages that provide support and reassur-
ance and put medical content in everyday language affect
how participants think and feel about their decisions.
According to the International Conference on
Harmonisation good clinical practice guidelines, for con-
sent to be valid, it must be properly informed and volun-
tarily given by a participant with the capacity to decide
whether to take part in the research [13]. This is particu-
larly relevant to obstetric and perinatal trials, such as the
Cord Pilot Trial, where it is important to consider the
context of women being in labour and/or in medical
emergency situations which can involve high levels of
stress and anxiety [14]. Whilst such situations do not
mean that women lack the capacity to provide valid con-
sent, they do mean that consent processes need to be
adapted to suit this particular context. Studies have
found that parents still want the opportunity to partici-
pate (or allow their infant to participate) in perinatal re-
search and value their role as decision makers [15–17],
and the oral assent pathway in our trial recognises that
women about to give birth have the capacity to make the
decision to participate. In our study, women recruited
from both oral assent and written consent pathways
showed understanding of the trial and intervention, dem-
onstrating their ability to make decisions at a difficult
time. Nevertheless, there was still some uncertainty for a
few women over aspects of the trial, such as which inter-
vention they were randomised to and follow-up. This un-
certainty is consistent with other studies of participants’
understanding of trial procedures after the intervention,
which have shown that parents often do not demonstrate
a comprehensive understanding of randomisation and
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information they are given [18–20]. In our study, any mis-
understandings could be due to the fact that the study in-
volved mothers of babies who were going to be born very
early and therefore the trial was secondary to other things
in women’s minds. This further highlights the need for in-
formation to be minimal and easy to understand for
women to be able to consider participation and give valid
consent, whether written or oral.
Strengths and limitations
To our knowledge, this is the first empirical study to evalu-
ate a novel process of seeking consent for perinatal research
when there is insufficient time for the usual single-stage in-
formed consent process. Use of detailed qualitative
methods allowed an in-depth exploration of women’s expe-
riences of these two alternative consent pathways. Most
women in our study were married or living with their part-
ner and were well educated, which is not typical of women
having very preterm birth. However, they may be more rep-
resentative of women who agreed to participate in the trial
because they have a similar distribution of age and gestation
at birth. Our results are based on a single trial, and other
factors may be more or less important in trials with differ-
ent risk and benefit profiles. It is also possible that women
may have been reluctant to criticise the trial because some
of the research team were also involved in their baby’s care,
but this is unlikely because the babies were now discharged
and at home. Furthermore, it is possible that the stressful
circumstances surrounding the birth influenced women’s
recall of the consent process. For example, a previous study
with parents of preterm babies demonstrated that just
under half of the parents reported a blurred memory of the
birth [21]. Finally, women who did not consent to take part
in the trial were not interviewed, which means that we were
unable to explore the experiences of this group.
Conclusions
These findings have several implications for issues of
intrapartum consent and future research on emergency
neonatal interventions. Overall, women’s experiences of
the two consent pathways were similar. Women in both
pathways were positive about their experiences of being
invited to participate in the trial, and they were particu-
larly positive about the staff who offered consent.
Although there were gaps in a minority of women’s ac-
counts regarding the benefits and risks of the interven-
tion, uncertainty over which arm of the trial they were
randomised to and follow-up procedures, women were
happy with the level of explanation received and
expressed that they had sufficient time and information
to make their decision to participate. Women recruited
following oral assent understood that lack of time lim-
ited the information available to them. Oral assent there-
fore seems an acceptable alternative for offering consent
in trials of low-risk interventions in emergency situa-
tions, and it has been incorporated into the latest guide-
lines for consent in obstetrics and gynaecology [7]. The
use of oral assent therefore merits further use and
evaluation. Future researchers might compare the two
consent pathways in low-risk interventions to see how
they impact parent (or patient) knowledge, satisfaction,
anxiety, and views about consent.
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